Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05720819 · ClinicalTrials.gov registry record · NA
Biofeedback-VR for Treatment of Chronic Migraine
A NA study of Virtual Reality and Chronic Migraine, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05720819 is a NA study of Virtual Reality and Chronic Migraine that has completed, run by University of Washington. The registered enrollment target is 50 participants, below the 90-participant average among 19 other Virtual Reality trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05720819, a NA study of Virtual Reality and Chronic Migraine, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Migraine is a common, debilitating neurologic condition affecting more than 900 million individuals worldwide. Established treatments for migraine include medications, vitamin and herbal supplements, neuromodulation, and behavioral treatment strategies. This study aims to determine whether a novel, home-based behavioral approach, combined biofeedback-virtual reality therapy, can improve self-reported migraine-related outcomes in individuals living with chronic migraine. In this randomized, controlled pilot study, 50 adults with chronic migraine are randomized to the experimental group (frequent use of a heart rate variability biofeedback-virtual reality device plus standard medical care; n=25) or wait-list control group (standard medical care alone; n=25). The primary outcome is reduction in mean monthly headache days between groups at 12 weeks. Secondary outcomes include mean change in acute analgesic use frequency, depression, migraine-related disability, stress, insomnia, and catastrophizing between groups at 12 weeks. Tertiary outcomes include change in heart rate variability and device-related user experience measures.
Conditions Studied
Interventions
- DEVICE Combined biofeedback-virtual reality device
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-09-09 |
| Est. Completion | 2022-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05720819
The ClinicalTrials.gov registry entry for NCT05720819 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90-participant average among 19 other Virtual Reality trials with a reported enrollment target (44% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Virtual Reality appearing as the primary indexed condition, and to 1 intervention - of which Combined biofeedback-virtual reality device is the first listed.
NCT05720819 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT05720819 about?
NCT05720819 is a clinical study titled "Biofeedback-VR for Treatment of Chronic Migraine". Migraine is a common, debilitating neurologic condition affecting more than 900 million individuals worldwide. Established treatments for migraine include medications, vitamin and herbal supplements, neuromodulation, and behavioral treatment strategies. This study aims to determine whether a novel, ...
What is the current status of trial NCT05720819?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2020-09-09. Estimated completion is 2022-03-01.
What conditions does trial NCT05720819 study?
This clinical trial studies the following conditions: Virtual Reality, Chronic Migraine, Biofeedback, Behavioral Treatment, Medication Overuse Headache.
What interventions are being tested in trial NCT05720819?
The interventions under investigation include: Combined biofeedback-virtual reality device (DEVICE).
Who is sponsoring clinical trial NCT05720819?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05720819 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Virtual Reality
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
The WOW Project (WOW): Wonders Of The World Through Virtual Reality for Hospitalized Children
RECRUITING · NA
-
VR-PMR for Post-Burn Symptoms
RECRUITING · NA
-
Cybersickness Prevention and Mitigation in Virtual Reality for Healthy Volunteers
RECRUITING · NA
-
Virtual Reality During Exercise Testing
RECRUITING · NA
-
Effects of Vestibular Training on Postural Control of Healthy Adults Using Virtual Reality
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.